Drug Development Drug Research Immune Response 
Crown Bioscience
AUGUST 2, 2021
In this blog we will explore immune-mediated inflammatory diseases (IMIDs) —which represent a diverse group of conditions characterized by an excessive and/or inappropriate immune response.
DrugBank
MAY 15, 2024
Its structure makes it incredibly difficult for drugs to bind effectively, which has stymied drug development for decades. The binding pockets on KRAS are shallow and polar , not ideal for the kinds of interactions needed for strong, effective drug binding.
NIH Director's Blog: Drug Development
FEBRUARY 16, 2021
ACTIV was founded last April to accelerate drug research that typically requires more than a decade of clinical ups and downs to develop a safe, effective therapy. They are called immune modulators because they help to minimize the effects of an overactive immune response in some COVID-19 patients.
Expert insights. Personalized for you.
52 
Let's personalize your content